SCHEMBL3597765

SCHEMBL3597765

C[CH]C[C@H](CCC)N1CCN(C)CC1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MC4R P32245 3/20 0.35
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3587426 1.00 MC4R (0.35) MC4RIDO1
SCHEMBL3588737 0.84 IDO1 (0.35) MC4RIDO1
SCHEMBL3587428 0.83 MC4R (0.40) MC4RIDO1
SCHEMBL3588742 0.79 MC4R (0.38) MC4RIDO1
SCHEMBL26178209 0.79 MC4R (0.38) MC4RIDO1
SCHEMBL24507522 0.76 MC4R (0.41) MC4RIDO1
SCHEMBL25921483 0.76 MC4R (0.41) MC4RIDO1
SCHEMBL24418758 0.76 IDO1 (0.50) MC4RIDO1
SCHEMBL24799343 0.74 MC4R (0.36) MC4RIDO1
SCHEMBL3585357 0.73 MC4R (0.35) MC4RIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029636-A1 Lck inhibitors NOVARTIS AG (CH) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029636-A1 Lck inhibitors LCK, ZAP70, FYN MC4R 3945/4885IDO1 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.